DJO Global reported net sales of $278.9 million and net loss of $29 million during the first quarter of 2012. The net sales represented an 11.7 percent increase over the net sales over the same period last year. The net loss for the first quarter was also higher than the same period last year, which was impacted by surgical non-cash items, non-recurring items and other adjustments. The company has provided a valuation allowance against a portion of its deferred tax assets due to the cumulative magnitude of such deferred tax assets.
The company's surgical implant business segment grew 8.3 percent over the same period last year to $17.8 million. The increase was driven by strong sales in the shoulder products — including the launch of the RSP Monoblock — and hip sales.
More Articles on Orthopedic Devices:
Zimmer's Q1 Knee & Hip Sales Up 2%, Spine Sales Drop
15 Spine Device Company Leadership Moves
U.S. Minimally Invasive Spine Devices to Top $2.6B by 2018
The company's surgical implant business segment grew 8.3 percent over the same period last year to $17.8 million. The increase was driven by strong sales in the shoulder products — including the launch of the RSP Monoblock — and hip sales.
More Articles on Orthopedic Devices:
Zimmer's Q1 Knee & Hip Sales Up 2%, Spine Sales Drop
15 Spine Device Company Leadership Moves
U.S. Minimally Invasive Spine Devices to Top $2.6B by 2018